Center for International Health, University of Bergen, Bergen, Norway
Search for other papers by Kjersti S Bakken in
Google Scholar
PubMed
Department of Microbiology, Innlandet Hospital Trust, Lillehammer, Norway
Search for other papers by Kristina Randjelovic Nermo in
Google Scholar
PubMed
Department of Clinical Science, University of Bergen, Bergen, Norway
Search for other papers by Bjørn Gunnar Nedrebø in
Google Scholar
PubMed
Search for other papers by Tim I M Korevaar in
Google Scholar
PubMed
Department of Research, Innlandet Hospital Trust, Lillehammer, Norway
Search for other papers by Tor A Strand in
Google Scholar
PubMed
caused overdiagnosis of (subclinical) hypothyroidism and subsequent overtreatment ( 4 , 5 , 6 ). However, there is a lack of data that quantify this potential increase in thyroid hormone therapy from a national perspective. Interestingly, the diagnostic
Search for other papers by Robert Rapaport in
Google Scholar
PubMed
Search for other papers by Peter A Lee in
Google Scholar
PubMed
Nemours/DuPont Hospital for Children, Wilmington, Delaware, USA
Search for other papers by Judith L Ross in
Google Scholar
PubMed
Search for other papers by Paul Saenger in
Google Scholar
PubMed
Search for other papers by Vlady Ostrow in
Google Scholar
PubMed
Search for other papers by Giuseppe Piccoli in
Google Scholar
PubMed
developed as practical tools to estimate the response to GH therapy for the diagnosis of growth hormone deficiency (GHD) ( 19 ), SGA ( 20 ) and ISS ( 21 ). The non-interventional American Norditropin Studies: Web-Enabled Research (ANSWER) Program was
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Brendan J Nolan in
Google Scholar
PubMed
Search for other papers by Aviva S Frydman in
Google Scholar
PubMed
Search for other papers by Shalem Y Leemaqz in
Google Scholar
PubMed
Search for other papers by Meg Carroll in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Mathis Grossmann in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Jeffrey D Zajac in
Google Scholar
PubMed
Department of Medicine (Austin Health), University of Melbourne, Heidelberg, Victoria, Australia
Search for other papers by Ada S Cheung in
Google Scholar
PubMed
Introduction Transgender (trans) individuals, including those who are binary and/or non-binary identified, undergoing feminising hormone therapy are often treated with oestradiol with or without anti-androgen therapy. Treatment allows the
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Hans Valdemar López Krabbe in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jørgen Holm Petersen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Fertility, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Louise Laub Asserhøj in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Trine Holm Johannsen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Peter Christiansen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Rikke Beck Jensen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Line Hartvig Cleemann in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Casper P Hagen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Lærke Priskorn in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Niels Jørgensen in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Katharina M Main in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Anders Juul in
Google Scholar
PubMed
International Centre for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health (EDMaRC), Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
Search for other papers by Lise Aksglaede in
Google Scholar
PubMed
; FSH, follicle-stimulating hormone; LH, luteinizing hormone; SDS, standard deviation score; total E2, total estradiol; TRT, testosterone replacement therapy. Anthropometric measurements and body composition in KS Patients with KS were
Search for other papers by Patrizia Bruzzi in
Google Scholar
PubMed
Search for other papers by Silvia Vannelli in
Google Scholar
PubMed
Search for other papers by Emanuela Scarano in
Google Scholar
PubMed
Search for other papers by Natascia Di Iorgi in
Google Scholar
PubMed
Search for other papers by Maria Parpagnoli in
Google Scholar
PubMed
Search for other papers by MariaCarolina Salerno in
Google Scholar
PubMed
Search for other papers by Marco Pitea in
Google Scholar
PubMed
Search for other papers by Maria Elisabeth Street in
Google Scholar
PubMed
Search for other papers by Andrea Secco in
Google Scholar
PubMed
Search for other papers by Adolfo Andrea Trettene in
Google Scholar
PubMed
Search for other papers by Malgorzata Wasniewska in
Google Scholar
PubMed
Search for other papers by Nicola Corciulo in
Google Scholar
PubMed
Search for other papers by Gianluca Tornese in
Google Scholar
PubMed
Search for other papers by Maria Felicia Faienza in
Google Scholar
PubMed
Search for other papers by Maurizio Delvecchio in
Google Scholar
PubMed
Search for other papers by Simona Filomena Madeo in
Google Scholar
PubMed
Search for other papers by Lorenzo Iughetti in
Google Scholar
PubMed
affecting the SHOX-coding region ( 8 ). Recombinant human growth hormone (rhGH) therapy is already approved for use in patients with SHOX-D in the USA, Europe and other countries ( 9 ), and it seems to have a growth-promoting activity similar to patients
Search for other papers by Urszula Smyczyńska in
Google Scholar
PubMed
Search for other papers by Joanna Smyczyńska in
Google Scholar
PubMed
Department of Paediatric Endocrinology, Medical University of Lodz, Lodz, Poland
Search for other papers by Maciej Hilczer in
Google Scholar
PubMed
Search for other papers by Renata Stawerska in
Google Scholar
PubMed
Search for other papers by Ryszard Tadeusiewicz in
Google Scholar
PubMed
Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
Search for other papers by Andrzej Lewiński in
Google Scholar
PubMed
Introduction Growth hormone (GH) therapy is widely approved in children with short stature caused by GH deficiency (GHD). It has also been documented that GH therapy may be beneficial in children with idiopathic short stature (ISS); however
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Nathalie Ly in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Search for other papers by Sophie Dubreuil in
Google Scholar
PubMed
EndoERN, APHP Consortium Pitie Salpetriere Hospital, Necker Hospital, Paris, France
Sorbonne University, Paris, France
Search for other papers by Philippe Touraine in
Google Scholar
PubMed
://doi.org/10.1016/j.fertnstert.2004.03.026 ) 16 Wirén L Boguszewski CL Johannsson G . Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy . Clinical Endocrinology 2002 57 235 – 239 . ( https://doi.org/10.1046/j.1365
Search for other papers by John E M Midgley in
Google Scholar
PubMed
Search for other papers by Rolf Larisch in
Google Scholar
PubMed
North Lakes Clinical, Department of Nuclear Medicine, Medical Department I, Ruhr Center for Rare Diseases (CeSER), 20 Wheatley Avenue, Ilkley LS29 8PT, UK
Search for other papers by Johannes W Dietrich in
Google Scholar
PubMed
Search for other papers by Rudolf Hoermann in
Google Scholar
PubMed
ineligible to participate in the study. This exclusion extended to other conditions and the use of comedications that may interfere with the resorption or measurement of thyroid hormones or with pituitary TSH. Patients with T 3 /T 4 combination therapy ( n
Search for other papers by María Dolores Rodríguez Arnao in
Google Scholar
PubMed
Search for other papers by Amparo Rodríguez Sánchez in
Google Scholar
PubMed
Search for other papers by Ignacio Díez López in
Google Scholar
PubMed
Search for other papers by Joaquín Ramírez Fernández in
Google Scholar
PubMed
Search for other papers by Jose Antonio Bermúdez de la Vega in
Google Scholar
PubMed
Search for other papers by Diego Yeste Fernández in
Google Scholar
PubMed
Search for other papers by María Chueca Guindulain in
Google Scholar
PubMed
Search for other papers by Raquel Corripio Collado in
Google Scholar
PubMed
Search for other papers by Jacobo Pérez Sánchez in
Google Scholar
PubMed
Search for other papers by Ana Fernández González in
Google Scholar
PubMed
Search for other papers by ECOS Spain Study Collaborative Investigator Group in
Google Scholar
PubMed
pathologies) and in sensitivity to the hormone ( 4 ). Treatment with r-hGH has been shown to be effective in children and adolescents with GHD, increasing short-term growth and adult height ( 5 , 6 ). GH therapy requires daily subcutaneous injections for long
Search for other papers by Guido Zavatta in
Google Scholar
PubMed
Search for other papers by Bart L Clarke in
Google Scholar
PubMed
replacement therapy. Since then a growing body of clinical studies has been published describing the long-term effects of recombinant human parathyroid hormone rhPTH(1–84), other forms of parathyroid hormone-based therapies, and PTH receptor 1 (PTHR1) agonist